Lini Subin, director — regulatory affairs, ELC Group, highlights EMA’s regulatory tools and support pathways that are available during development.
In recent years, the pharmaceutical world has been witnessing huge demand to serve unmet health needs and deliver early access to medications. Many companies are focusing on R&D innovation to meet these needs, however, the regulatory pathway for early access to medicines is always a challenge globally.